Strategy Inc. was able to perform a market analysis and technology assessment that permitted our company to monetize our intellectual property outside of our clinical focus.” Paul McCormick, CEO, Endologix

Endologix develops minimally invasive treatments for vascular diseases. The company is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).